Trevi Therapeutics Inc.

NASDAQ: TRVI · Real-Time Price · USD
7.51
0.02 (0.27%)
At close: Aug 15, 2025, 3:59 PM
7.52
0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT

Trevi Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
147K 123K 43K 50K
Gross Profit
-147K -123K -43K -50K
Operating Income
-51.52M -33.92M -29.91M -32.48M
Interest Income
3.6M 4.75M 1.74M 10K
Pretax Income
-47.94M -29.1M -29.19M -33.96M
Net Income
-47.91M -29.07M -29.15M -33.94M
Selling & General & Admin
12.15M 10.24M 10.07M 9.49M
Research & Development
39.38M 23.68M 19.83M 22.98M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
51.52M 33.92M 29.91M 32.48M
Interest Expense
4K 391K 780K 1.2M
Selling & Marketing Expenses
n/a 287K n/a n/a
Cost & Expenses
51.52M 33.92M 29.91M 32.48M
Income Tax Expense
-30K -32K -36K -21K
Shares Outstanding (Basic)
101.04M 99.03M 64.54M 22.84M
Shares Outstanding (Diluted)
101.04M 99.03M 64.54M 22.84M
EPS (Basic)
-0.47 -0.29 -0.45 -1.49
EPS (Diluted)
-0.47 -0.29 -0.45 -1.49
EBITDA
-47.79M -33.8M -28.02M -32.71M
EBIT
-47.94M -33.92M -28.06M -32.76M
Depreciation & Amortization
147K 123K 43K 50K